您的购物车当前为空
Y16 是一种 G 蛋白偶联的 Rho GEFs 抑制剂,与 Rhosin/G04 协同作用,抑制 LARG-RhoA 相互作用、RhoA 激活和 RhoA 介导的信号传导功能。Y16 还是 LARG 的特异性抑制剂,Kd 值为 76 nM。

Y16 是一种 G 蛋白偶联的 Rho GEFs 抑制剂,与 Rhosin/G04 协同作用,抑制 LARG-RhoA 相互作用、RhoA 激活和 RhoA 介导的信号传导功能。Y16 还是 LARG 的特异性抑制剂,Kd 值为 76 nM。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 263 | In Stock | |
| 2 mg | ¥ 369 | In Stock | |
| 5 mg | ¥ 573 | In Stock | |
| 10 mg | ¥ 956 | In Stock | |
| 25 mg | ¥ 1,590 | In Stock | |
| 50 mg | ¥ 2,380 | In Stock | |
| 100 mg | ¥ 3,580 | In Stock | |
| 500 mg | ¥ 7,900 | In Stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 627 | In Stock |
Y16 相关产品
| 产品描述 | Y16 is a G protein-coupled Rho GEFs inhibitor that synergizes with Rhosin/G04 to inhibit LARG-RhoA interaction, RhoA activation, and RhoA-mediated signaling. Y16 is also a specific inhibitor of LARG with a Kd of 76 nM. |
| 靶点活性 | LARG:76 nM (Kd) |
| 体外活性 | 方法:Y16(5,10,30,50μM) 处理MCF7 乳腺细胞,研究了 Y16 对生长、迁移和侵袭的影响,以及乳腺球形成、乳腺癌细胞的活动、与致瘤潜力相关的特性。 |
| 分子量 | 384.43 |
| 分子式 | C24H20N2O3 |
| CAS No. | 429653-73-6 |
| Smiles | Cc1cccc(COc2cccc(\C=C3/C(=O)NN(C3=O)c3ccccc3)c2)c1 |
| 密度 | 1.273 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| 溶解度信息 | DMSO: 10 mg/mL (26.01 mM), Sonication is recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
评论内容